At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 48 enrolled
Drug / intervention
high arginine nutritional supplement (Nestle's Impact AR)dietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy
In Brief
A Phase 2 clinical trial evaluating high arginine nutritional supplement (Nestle's Impact AR) for Bladder Cancer. Completed, enrolled 48 participants across 1 site.
Detailed Summary
To provide patients with bladder cancer who are scheduled to undergo radical cystectomy with a preoperative high-arginine nutritional supplement. The investigator will measure patient adherence to the regimen, tolerability of the supplement and feasibility of supplementation. Secondary outcome measures will include differences in length of stay and complication rate between groups.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBladder Cancer
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJul 2015
First PostedJan 2016
Primary CompletionDec 2016
TodayJul 2026
First PostedJan 13, 2016
Enrollment StartJul 1, 2015
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 10.5 years ago
Interventions
high arginine nutritional supplement (Nestle's Impact AR)dietary
Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy